Health Archive » December, 2021

Health - December, 2021

273 articles

• NY Jury Holds Teva Liable After Opioid Trial
• The Most-Read Legal Industry Guest Articles Of 2021
• Endo Gives Texas $63M In Latest Opioid Deal
• High Court To Review Federal Vaccine Mandates Next Month
• 5th Circ. Won't Revive Walmart's Opioid Suit Against Feds
• Opioid Judge's 'Many Errors' Ruined Trial, Pharmacies Charge
• Allergan Unit Says Linda Evangelista's $50M Suit Time-Barred
• As Hacks Hit A Nerve, Admin. Pushed Reporting Of Breaches
• Vaxart Can't Ditch Claims Co. Lied To Investors About Vaccine
• Man's Fentanyl Abuse Absolves Pharmacy, Pa. Justices Say
• Injunctions May Only Pause Gov't Contractor Vaccine Mandate
• Law360's Tort Report: Dismissal Bid In Glenn Frey Death Suit
• Pfizer Gets FDA Emergency Use Authorization For COVID Pills
• Judge Overrules 'State Secrets' Concerns In Valsartan MDL
• What DOJ's Cyberfraud Initiative Means For Health Cos.
• Texas Panel Revives Stroke Patient's Malpractice Suit
• Horizon Healthcare Beats Revived Data Breach Suit, For Now
• A Law Firm Leader's Guide To Seeking Effective Feedback
• Top 5 Government Contracts Of 2021
• Pa. Justices Say Two Disputed Words Don't Warrant New Trial
• Biggest Corporate, Institutional, Gov't Injury Payouts Of 2021
• Janssen Denied Early Defeat Of HIV Medication FCA Suit
• DOJ Opioid Trial Team Tainted By Kirkland Ties, Ex-CEO Says
• Maine Asks 1st Circ. To Uphold Medical Pot Residency Rule
• 27 States, Groups Appeal Vax-Or-Test Rule To Justices
• Ill. Judge Refuses To Block Chicago, State Vax Mandates
• Fla. Man Fights Pfizer's Escape Bid For Chantix Suit
• Purdue Asks To Keep Lawsuits Frozen Pending Ch. 11 Appeal
• The Biggest Personal Injury Decisions And Verdicts Of 2021
• Biden's Omicron Plan Details More At-Home Tests, Vax Sites
• Horizon, Pa. Pharmacy Settle $10M Insurance Fraud Suit
• Mylan Says Unharmed EpiPen Loyalists Undercut Class Cert.
• How Medical Device Cos. Can Limit Enforcement, Legal Risks
• Harvard Prof Convicted Of Lying About China Ties
• Bankrupt Hospital's Ex-Owner Challenges Blocked Loan
• Jackson Lewis Wants Conn. Doc's Defamation Bid Axed
• What Court Clash On Fla. Law Means For Lost Profits Claims
• Ropes & Gray Plans LA Office, Adds Paul Hastings PE Atty
• Washington Nationals Tap Lorenger & Carnell For Vax Suit
• NJ Firm Wants To Toss Suit Over Benicar MDL Atty Fees
• Smith & Nephew Tries To Sink Pre-2009 Hip Implant Claims
• Microsoft's $19.7B Nuance Buy Gets Unconditional EU Nod
• Taft Stettinius Adds 3 Veteran IP Attorneys In DC
• Mayer Brown-Led TJC Nabs $5B For Top Fund In Firm History
• DOJ Fight Over Treatment Of No-Poach Cases Heats Up
• 11th Circ. Backs Hollister's $9M Win In Incontinence IP Row
• 3rd Circ. Affirms Unions' Win In Nursing Homes' Fraud Case
• Hiding China Ties Key To Harvard Prof's Grants, Jury Told
• Emerging Arbitration Issues In Outsourcing Disputes
• Federal Defense Can't Keep COVID Row Out Of Pa. State Court
• 7th Circ. Again Backs Kidney Patient's $31M Med Mal Win
• University Of Chicago Prof. Charged With Insider Trading
• Insurers Tell 11th Circ. To Nix Medical Co.'s Coverage Suit
• Schumer Vows Vote On BBB Act After Manchin Defection
• Embracing ESG: Whirlpool CLO Talks Structural Improvement
• Oracle Inks $28.3B Deal For Medical Records Co. Cerner
• Moderna Backs Off COVID Vaccine Patent In Dispute With NIH
• Split 6th Circ. Nixes 5th Circ. Stay Of Biden's Vax-Or-Test Rule
• Holmes' Fate In Jury's Hands As Criminal Fraud Trial Wraps
• Mallinckrodt Balks At Bid To Withdraw Acthar Antitrust Claims
• Seismic Purdue Ruling May Finally Get High Court's Attention
• LA Fitness Blames Virus For Closures In Revised Suit
• Cannabis Bill Roundup: GOP Reps. Chide Biden's Pot Inaction
• Wage-Fixing Defendant Seeks Rethink On Rejected DOJ Deal
• Pharmacy Benefit Manager Lobby Calls 8th Circ. Loss 'Wrong'
• Fla. High Court Is Wrong To Ban CLE Diversity Requirements
• The 6 Most Important Bid Protest Decisions Of 2021
• Health Hires: Balt, McDermott Will & Emery
• Elite Horse Trainer Navarro Gets 5 Years In Doping Scandal
• Investor Seeks Del. TRO For NJ Hospitals' 'Fire Drill' Deal
• Hollywood Weight Loss Doc Guilty In $355M Insurance Scam
• Texas Jury Convicts Californian In $28M Kickback Scheme
• Worker Can't Be Fired For Rebutting Review, Mass. Court Says
• The Biggest COVID-19 Business Interruption Rulings Of 2021
• 7th Circ. Revives 2 Cook Medical Vein Filter Suits
• What We Learned About Logistics In 2021
• Biden Asks Supreme Court To Revive Health Worker Vax Rule
• Davis Wright, Partner Sanctioned $40K For 'Bad Faith' Filings
• FDA To Allow Abortion Pills By Mail, Amid High Court Clash
• FDA Tosses Par Pharma's Anti-Generic Bid, Vows FTC Referral
• Nobel Hopes Drove Harvard Prof To China Program, Jury Told
• Purdue Pharma's Ch. 11 Plan Is Unraveled On Appeal
• CDC Panel Recommends Pfizer, Moderna Over J&J Vax
• Hungarian Pop Star Sues DHS For 1-Month Detention
• NY Surgeon Faces Renewed Suit Over Spinal Implant Injuries
• Texas Court Temporarily Stops Health Care Vaccine Mandate
• Lawyers Must Prepare For Contract Tech Co. Consolidation
• Illumina Investor Eyes Bail Amid Insider Trading Appeal
• Prognosis Is Mixed For COVID-19 Post-Acute Care Staffing
• High Court Speeds Up Texas Abortion Fight In 5th Circ.
• US Trustee Seeks Ch. 11 Examiner For J&J Talc Liability Unit
• Allianz Defeats Ore. Health System's Virus Coverage Suit
• Disputing Plaintiff Expert Testimony In Product Liability Cases
• ACLU Urges DHS To Offer COVID Boosters To Detainees
• Defunct Opioid Distributor's Compliance Manager Takes Plea
• Holmes' 'Risky' Decision To Testify Could Save Her, Attys Say
• Mylan Can't Decertify EpiPen Antitrust Action Ahead Of Trial
• Cannabis Advocacy Org Urges Fed Action On CBD Regulation
• ERISA Suit Against UnitedHealth Unit Wins Class Status
• 5th Circ. Dials Back Block Of Health Care Vaccine Mandate
• Centene Hits Gilead With HIV Generic Antitrust Suit
• FDA Sends Medtronic Warning Over Diabetes Facility Issues
• $15M NJ Hospital Fight Over Failed Deal Left Up To Jurors
• Jones Day Can Rep J&J Talc Unit In Ch. 11 For Now
• Get Ready Now For 2022's New Hospice Oversight
• Insurer Ordered To Defend WTA In $10M Blood Test Arbitration
• Philadelphia Civil Litigator Launches Own Mediation Firm
• AKT Must Pay Some Of Celeb Trainer's Fees After Failed Suit
• Health Care Tech Platform Co. Valued At $3.2B After Series E
• How Budget Bill Could Affect Employer Health, Benefit Plans
• Faegre Drinker Boosts DC Consulting Practice, Adds Director
• Harvard Prof Rips 'Mangled' China-Ties Case As Trial Opens
• BigLaw's Big Guns Of Revenue Keep Growing
• Opioid Makers Cement Calif. Win As Judge Spurns Objections
• Discrepancy In Fraud Standards Is Overstated, Justices Told
• Okla. Law Firm Tries To End Ex-Employee's Pot Licenses Suit
• Ill. Panel Upholds Doc's $4.5M Arbitration Win In Wage Row
• Opioid Treatment Provider Ophelia Grabs $50M In Series B
• 4 Highlights From FDA Nominee Hearing
• Feds Urge DC Circ. Not to Rethink Tribal Health Care Order
• 5 Benefits Rulings From 2021 That Attorneys Should Know
• What New FDA Policy Means For COVID Tests And Beyond
• 'Crying' Atty Won't Undo $1.3M Cancer Misdiagnosis Verdict
• How Firms Can Adapt Amid COVID's Shifting Legal Needs
• Tornadoes Damaging But Manageable, Insurer Analysts Say
• 3-Part Ch. 11 Stalking Horse Sale OK'd For Teligent
• Monsanto Successors Agree To $17.9M Superfund Cleanup
• Mass. AG To Appeal Toss Of Landmark COVID Neglect Case
• Prestige Draws Young Attys, But Keeping Them Takes Work
• Split 5th Circ. Won't Block United Vax Mandate Amid Appeal
• NY Opioid Deliberations Delayed After Rancorous Closing Day
• Mallinckrodt Says $1.75B Ch. 11 Opioid Deal Is Reasonable
• 11th Circ. Tosses Mom's Suit Over Murdered Child's Remains
• 3rd Circ. Won't Free Doc From Ex-Professor's Defamation Row
• Justices Won't Review FTC's Impax Ruling
• Past Guidance Gives NYC Employers Clues On New Vax Rules
• Contractor Says Resold Workout Machines Are Fed's Problem
• Embracing ESG: Synchrony Counsel Talk Role Of Legal Teams
• High Court Won't Block NY Health Care Worker Vax Mandate
• Pa. DAs Say AG's $26B Opioid Deal Steps On Their Suits
• Convergys Wraps Up Fired Worker's FMLA Suit
• Justices Won't Hear J&J Challenge To Miss. AG's Talc Trial
• Analyzing FCA Materiality Defense Outcomes Under Escobar
• Justices Want Feds' Input On Anthem Drug Price ERISA Case
• Prestige Leaders: A Look At Our New Law Firm Ranking
• The 2021 Law360 Pulse Prestige Leaders
• Prestige Leaders: Sizing Up Firms By Revenue
• Holmes Jury Instructions Fight Touches On Celebrity, Balwani
• Court Asked To Create Fund In Atrium Defective Mesh MDL
• One Of 3M's N95 TM Suits Just Got More Complicated
• 7th Circ. Deals Policyholders 'Body Blow' In Virus Ruling
• Cannabis Bill Roundup: The Prefiling Season Kicks Off
• The Top Product Liability Cases Of 2021
• Shkreli, Vyera To Settle Out Of BCBS Antitrust Class Action
• Mallinckrodt Calls Opioid, Acthar Deals Vital To Ch. 11 Plan
• How Personnel Files Can Affect Medical Malpractice Claims
• Rite Aid Broke Law By Changing Benefits, NLRB Judge Finds
• Texas Justices To Hear Blue Cross $3M Tax Refund Fight
• Don't Miss It: Skadden, Willkie Guide Week's Hot Deals
• DOJ's China Initiative On Trial As Harvard Prof. Faces Jury
• Pomerantz, Levi & Korsinsky To Co-Lead Del. StoneMor Suits
• Taxation With Representation: Ashurst, Freshfields, Gibson
• Justices Let Texas Keep Its Abortion Law, But Clinics Can Sue
• Fla. Justices Side With State Farm On PIP Rates
• US Trustee Wants Jones Day Booted From J&J Talc Ch. 11
• No Teva Execs Testified In NY Opioid Trial, Jury Told
• Federal Judge Puts Calif. Pay-For-Delay Ban On Hold
• SEIU Says Hospital Owes $2.3M In Benefit Fund Contributions
• Faegre Drinker Grabs Benefits Expert From Jackson Lewis
• WilmerHale Steers Jeb Bush-Led SPAC's $200M IPO
• Bradley Arant Adds Ex-Gibson Dunn Atty To Litigation Team
• 3rd Fla. Federal Judge Recuses Himself In Battle Over Fees
• Weintraub Tobin Merges With Sacramento Health Care Firm
• Spinal Injury Not Evidence To Be Preserved, NY Court Finds
• For Junior Lawyers, Authenticity And A Solid Pitch Are Key
• J&J Hip Implant FCA Case Tossed Over Secret Info Use
• Feds Say Chicago Doc Used Veterinary Catheters On Humans
• Theranos Closings Near As Elizabeth Holmes Rests Defense
• Talc Claimants Say J&J Abusing Ch. 11 With Trust Motion
• Surgical Care Can't Get Antitrust Trial 'Preview,' DOJ Says
• Opioid Sales Parody Videos Didn't Sway Docs, Jury Told
• NJ Pot Regulator Approves Delayed Medical Shop Licenses
• Ex-Insys Staffer Skirts Prison For Fentanyl Bribe Scheme
• Feds Say Tenant With Emotional Support Parrots Faced Bias
• Eversheds Guides Cannabis-Focused REIT In $100M IPO
• Del. Justices Urged To Give Standing For SmileDirectClub Suit
• A Compliance Primer For Attorneys Outsourcing Legal Work
• Ex-Medicaid Fraud Director Joins Barclay Damon In NYC
• Allergan Strikes $200M Deal To Exit NY Opioid Trial
• Brown Rudnick Adds FDA Expert To Life Sciences Group
• 3 Firms Lead £1.2B PE Buyout Of British Pharma Co. Clinigen
• 3 Firms Build $3.2B Deal For Black & Decker's Security Biz
• Holmes Defends Theranos' 'Aggressive' IP Protection At Trial
• Patient's Med Mal Suit Tossed Over Expert Witness Experience
• Former Shkreli Co. Inks Deal Worth Up To $40M With FTC, AGs
• Mallinckrodt Exec Says Ch. 11 Plan A Fair Deal For Creditors
• 3rd Circ. Prods FTC Over AG Approval Of NJ Hospital Merger
• Opioid Jury Finally Sees Teva's Movie-Parody Sales Videos
• Ga. Surgery Biz To Pay $3M To End False Claims Suit
• Calif. Justices Told No Slippery Slope In Med Mal Cap Case
• Full Fed. Circ. Told Teva Overreacting In Skinny Label IP Case
• What Vaccine Mandate Injunctions Mean For Health Employers
• Ex-Clinic Director Seeks Early Win In FCA Kickbacks Suit
• Justices Urged To Fix Law On Medical Pot Reimbursements
• DC Circ. Appears Skeptical Of FCC Wireless Antenna Rules
• Del. Superior Judge To Oversee Chancery Merger Dispute
• J&J Talc Sub Names Pick For Ch. 11 Future Claims Rep
• Feds Can't Escape Suit Over Ex-West Point Cadet's Suicide
• When And How To Depose Fact Witnesses Remotely In 2022
• Fla. Pharmacy Owner Convicted Of Mail Fraud
• 5th Circ. Dubious Virus Death Suits Belong In Federal Court
• Justices Won't Touch Migrant Kids' Revived Mental Health Suit
• Jury Gives Composite Resources Win In Tourniquet IP Row
• 11th Circ. Denies Fla. Bid To Halt Fed Health Workers Vax Rule
• DOJ Wants 1st Wage-Fixing Win To Become 1st Domino
• SEC Hits Dialysis Co., Execs With Accounting Fraud Claim
• Justices Told Fed. Circ. Wrongly Kills Patents PTAB Upholds
• Del. Justices Pick Contract Over Bad Math In $750M Merger
• Feds Say NJ Pharma CEO Pilfered Nearly $4M From His Co.
• Sackler Family Denies Pre-Ch. 11 Looting Of Purdue Pharma
• Elite Horse Trainer Navarro Asks For Leniency In Doping Case
• 9th Circ. Won't Revisit Feds' Win In Tribal Exec's Firing Suit
• High Court Won't Hear NC Hospital System Antitrust Challenge
• Blood Clot Device Maker Must Face Suit In Ill., Court Rules
• JP Morgan Ruling May Have Broad Insurance Implications
• Embracing ESG: PayPal CLO Talks Gauging Impact And Intent
• Justices Won't Review Nursing Home Arbitration Case
• Mallinckrodt Escapes $320M Acthar Antitrust Claim In Ch. 11
• Feds Seek To Stay Order Blocking Contractor Vax Mandate
• Walgreens Medicaid FCA Suit Tossed Over Federal Law Clash
• Feds Fight To Keep Texas Out Of Title 42 Defense
• Cannabis Bill Roundup: House Members Pitch New CBD Bill
• Holmes Attys Rip 'Confusing' Jury Instructions On Fraud
• Accessible Phone Co. To Pay $40.5M For FCC Rule Violations
• Maryland Atty Charged With $8.5M Escrow Fraud In NY Court
• Zoll Medical Escapes Liability For Alleged Defibrillator Defect
• How Growing Cyber Scrutiny Affects Corporate Compliance
• Parents Renew Injunction Bid On Pa. School Mask Mandate
• Class Attys Get $540K In Dollar General False Ad Suit
• Hughes Hubbard Adds Former US Attorney To DC Shop
• 3rd Circ. Preview: BLM Masks, $1.4B Award Fight End 2021
• Medicinal Standards Org Urges More Testing Of Delta-8 THC
• NY Court Revives Faulty Heart Valve Replacement Suit
• Claims Court Won't Extend FLSA Deadline In VA Overtime Suit
• Plan OK Ends 'Complicated' Nursing Home Biz Ch. 11
• Classwide Deal Complicates CaptureRx Breach Venue Fight
• Columbia, NY Presbyterian To Pay $71.5M For OB-GYN Abuse
• Alaska Tribal Health Consortium Hits Feds With $41.7M Suit
• Planned Parenthood Cyberattack Affects 400,000 Patients
• Texas Hospital Inks $18M Deal To End False Claims Fight
• Attys Seek $113M In Fees From Glumetza Buyers' $454M Deal
• FTC Pushing Caris Life Sciences For Merger Challenge Docs
• Health Ministry Estate To Pursue Admin Firm For Excess Fees
• 6th Circ. Affirms No Intervention In Flint Water Deal
• Ga. Residents Fight Site Owner's Bid To Escape Cancer Suits
• Gov't Contracts Of The Month: Meds, Jets, Military Moves
• Medical Association Wants States' Vax Mandate Suit Denied
• Lawmakers Urge VA To Let Vets Access Medical Pot
• Buchanan Ingersoll Objects To Fee Split In Discovery Dispute
• Clover Health Sued In Del. Over Merger Disclosure Failures
• Talc Claimants Seek To Toss J&J Unit's 'Manufactured' Ch. 11
• Yellen Sticks By $400B IRS Enforcement Revenue Estimate
• CVS Must Face Illinois Suit Over Repeated Robocalls
• Judge Unsure If He Can Rule On Future Mallinckrodt Deal
• Union Challenges Pa. Nursing Home's Staff Vaccine Mandate
• Avoiding Audit Disaster After Receiving A Disaster Grant  
• Imerys, Cyprus Get Go-Ahead For Mediation In Ch. 11 Cases
• Ohio Opioid Verdict Brings Focus To Role Of Pharmacists
• Chancery Tosses Most Counts Aimed At Vaccine Firm Insiders
• NorthShore Workers Denied Injunction In Vax Mandate Suit
• Insurer Liable For $4.8M In Clinic Damage, Health Co. Says
• NMC Carried Out $1B Fraud Through UK Unit, UAE Bank Says
• Conservative Justices Consider Overruling Roe V. Wade